Neue Investoren erwerben Aktien von Airway Medix
Neue Investoren haben 11,6 Millionen Aktien von Airway Medix für rund 3,944 Millionen PLN, etwa 900.000 EUR, erworben. Nach der Transaktion hält CoOpera 12,41 Prozent und Kröner Medizintechnik 3,54 Prozent des Unternehmens.
Volltext auf Englisch (Original)
Warsaw, November 20, 2023: Airway Medix is finalizing agreements regarding the acquisition of issue shares within the authorized capital in the amount of PLN 3.944 million (EUR 900,000) by new investors: CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group. New investors will invest up to EUR 2 million and will be operationally involved in the commercialization of products on the EU and US markets.
As a result of the agreements, 11.6 million shares were acquired, and CoOpera Finanzierungen Deutschland and Kröner Medizintechnik will become owners of 12.41 percent and 3.54 percent of the increased share capital.
Airway Medix focuses on innovative medical devices supporting the process of mechanical ventilation of patients, holding international patents. Partners, thanks to their experience in the industry, will support product development and commercialization processes.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Pressemitteilungen erscheinen so, wie Airway Medix S.A. sie herausgegeben hat. Produktaussagen folgen der Gebrauchsanweisung.
